Related Experiment Video
Updated: Jun 5, 2025

Highly Sensitive Measurement of Glomerular Permeability in Mice with Fluorescein Isothiocyanate-polysucrose 70
Published on: August 9, 2019
Effect of Uremic Toxins and Methoxy-PEO Chain Density on Plasma Protein Adsorption
Aishwarya S Pawar1, Ayda Ghahremanzadeh1, Mehdi Ghaffari Sharaf1
1Department of Chemical and Materials Engineering, University of Alberta, Edmonton, Alberta T6G 2V4, Canada.
Abstract:
Protein adsorption can direct the host response to blood-contacting biomaterials. Poly(ethylene oxide) (PEO) is commonly employed to minimize nonspecific protein adsorption. Although chain density has been observed to play a role in the inherent resistance of protein adsorption by end-tethered films of PEO, only a few papers correlate the change in PEO chain densities with the adsorbed plasma protein composition. Almost all studies rely upon blood from healthy patients for these studies even though they are applied to the unhealthy. In the case of patients with kidney failure, there is a remarkable change in the blood composition due to retained metabolites. In the pursuit of personalized dialysis, we must address this dearth in the literature regarding the effect of metabolite accumulation in the blood compartment on the adsorption of protein to blood-contacting biomaterials. To this end, surface films of different methoxy-PEO (mPEO) chain densities were used to evaluate the changes in adsorbed proteins in the presence of uremic metabolites (i.e., uremic toxins). End-tethered mPEO films were characterized using contact angles, ellipsometry, and X-ray photoelectron spectroscopy. Plasma protein adsorption was conducted with and without uremic toxins commonly found in patients with end stage kidney disease, and the adsorbed protein profile was identified using immunoblots. It was found that the presence of uremic toxins led to a notable increase in the adsorption of almost all of the proteins. It was evident that while chain density plays a role in overall protein resistance, the effect of uremic toxins led to substantial increases in adsorbed proteins and needs to be considered when designing next-generation blood-contacting materials.
More Related Videos
Related Concept Videos
Drug Distribution: Plasma Protein Binding
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Hepatic Drug Clearance: Effect of Protein Binding
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
Physiological Pharmacokinetic Models: Assumption with Protein Binding

